References

Diagnostic and statistical manual of mental disorders: DSM-5.Washington, DC: American Psychiatric Association; 2013

Anderson IM. Meta-analytical studies on new antidepressants. British Medical Bulletin. 2001; 57:(1)161-178 https://doi.org/10.1093/bmb/57.1.161

Aronson JK. Balanced prescribing – principles and challenges. British Journal of Clinical Pharmacology. 2012; 74:(4)566-572 https://doi.org/10.1111/j.1365-2125.2012.04413.x

Cipriani A, Furukawa TA, Salanti G Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018; 391:(10128)1357-1366 https://doi.org/10.1016/S0140-6736(17)32802-7

Cleare A, Pariante CM, Young AH Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015; 29:(5)459-525 https://doi.org/10.1177/0269881115581093

Duffy L, Bacon F, Clarke CS A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial. Trials. 2019; 20:(1) https://doi.org/10.1186/s13063-019-3390-8

Huynh NN, McIntyre RS. What Are the Implications of the STAR*D Trial for Primary Care? A Review and Synthesis. Prim Care Companion J Clin Psychiatry. 2008; 10:(2)91-6

British National Formulary. 77.London: British Medical Association and Royal Pharmaceutical Society; 2019

Depression in adults. 2019. https://bestpractice.bmj.com/topics/en-gb/55 (accessed 22 July 2019)

Mars B, Heron J, Gunnell D, Martin RM, Thomas KH, Kessler D. Prevalence and patterns of antidepressant switching amongst primary care patients in the UK. J Psychopharmacol. 2017; 31:(5)553-560 https://doi.org/10.1177/0269881117693748

Mental Health Foundation. Mental Health Statistics: depression. 2018. https://www.mentalhealth.org.uk/statistics/mental-health-statistics-depression (accessed 29 July 2019)

Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ. 2009; 339 https://doi.org/10.1136/bmj.b3999

National Institute for Health and Care Excellence. Clinical Knowledge Summaries. 2015. https://cks.nice.org.uk/depression#!background (accessed 22 July 2019)

National Institute for Health and Care Excellence. Depression in adults: recognition and management. [CG90]. 2018. https://www.nice.org.uk/guidance/cg90/chapter/1-Guidance#treatment-choice-based-on-depression-subtypes-and-personal-characteristics (accessed 22 July 2019)

Nutt DJ. Prescribing antidepressants post Cipriani et al. J Psychopharmacol. 2009; 23:(8)865-6 https://doi.org/10.1177/0269881109106958

Rodda J, Walker Z, Carter J. Depression in older adults. BMJ. 2011; 343 https://doi.org/10.1136/bmj.d5219

Smith L, Gilhooly K, Walker A. Factors influencing prescribing decisions in the treatment of depression: a social judgement theory approach. Applied Cognitive Psychology. 2002; 171:(1)51-63 https://doi.org/10.1002/acp.844

Taylor WD. Clinical practice. Depression in the elderly. N Engl J Med. 2014; 371:(13)1228-36 https://doi.org/10.1056/NEJMcp1402180

Managing depression in the primary care setting

02 August 2019
Volume 1 · Issue 8

Abstract

Depression affects more than 300 million people worldwide. The condition is thought to result from a complex interaction of social, biological and psychological factors. It is characterised by persistent low mood, and/or loss of pleasure in most activities over a 2-week period. Depression can be further categorised into mild, moderate and severe depression. In adults over the age of 65 years, depression tends to be as a result of comorbidities. There are various pharmacological and non-pharmacological treatments available for the condition. In the primary care setting, it is important to ensure that the patient is followed up regularly. Research into the various pharmacological treatment options is most welcome in improving care for patients suffering from depression.

It is estimated that depression is the third most common reason for GP consultations in the UK (National Institute for Health and Care Excellence (NICE), 2015). Statistics from 2014 reveal that there was a 1.5% increase from 2013 to 19.7% of patients over the age of 16 years in the UK suffering from either anxiety or depression (Mental Health Foundation, 2018). However, depression is often under-diagnosed and incorrectly treated (Smith et al, 2002). This article will explore the definition of depression, treatment options in adults and prescribing practice in primary care. The management of depression in children, adolescents and pregnant patients is beyond the remit of this article.

Depression is characterised by persistent low mood and/or loss of pleasure in most activities and a range of associated emotional, cognitive, physical, and behavioural symptoms (NICE, 2015). The DSM-5 diagnostic criteria requires the presence of at least five out of a possible nine symptoms (Table 1) over a 2-week period for a diagnosis to be made (American Psychiatric Association (APA), 2013). The symptoms must include persistent low mood and/or loss of interest or pleasure in all or almost all activities most days (APA, 2013). Other associated symptoms include weight loss/gain, appetite change, slowing down of thought or physical movement, fatigue, feeling of worthlessness, poor concentration and suicidal ideation (APA, 2013; Cleare et al, 2015; NICE, 2015; MacKinnon et al, 2019).

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month